PureTech Health, a biotech company in Boston, believes it might have a treatment for Covid-19 survivors facing the risk of long-term lung injuries.
With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil.
In addition, there’s still an unmet medical need for patients with locally advanced, inoperable pancreatic cancer (LAPC). In fact, PharmaCyte Biotech (PMCB) is hoping to change …
A clinical trial for the first drug using the biotech firm’s transport vehicle, an enzyme replacement therapy for Hunter syndrome, is expected to start soon
US biotech company Moderna announced on 18 May that results of its first phase of clinical trials involving humans showed that patients given its potential COVID-19...
Over the last couple of months, companies have found a way to muster up an effort to align their objectives
India witnessed 8,390 cases in 24 hours on the second consecutive day. The total case count of coronavirus disease mounted to 1,90,535 on Monday.